In recent trading session, Mangoceuticals Inc (NASDAQ:MGRX) saw 0.8 million shares changing hands at last check today with its beta currently measuring 2.40. Company’s recent per share price level of $1.6 trading at $0.02 or 1.27% at last check today assigns it a market valuation of $17.03M. That most recent trading price of MGRX’s stock is at a discount of -378.75% from its 52-week high price of $7.66 and is indicating a premium of 17.5% from its 52-week low price of $1.32. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.14 million shares which gives us an average trading volume of 262.80K if we extend that period to 3-months.

Mangoceuticals Inc (NASDAQ:MGRX) trade information

Mangoceuticals Inc’s shares saw a change of -75.19% in year-to-date performance and have moved 4.58% in past 5-day. Mangoceuticals Inc (NASDAQ:MGRX) showed a performance of -17.52% in past 30-days. Number of shares sold short was 0.12 million shares which calculate 0.56 days to cover the short interests.

Mangoceuticals Inc (NASDAQ:MGRX)’s Major holders

Insiders are in possession of 27.82% of company’s total shares while institution are holding 0.66 percent of that, with stock having share float percentage of 0.91%. Investors also watch the number of corporate investors in a company very closely, which is 0.66% institutions for Mangoceuticals Inc that are currently holding shares of the company.

On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of May 31, 2025 , the former fund manager was holding 10.54 shares of worth $16806.0 or 0.10% of the total outstanding shares. The later fund manager was in possession of 3.25 shares on May 31, 2025 , making its stake of worth around $5175.0 in the company or a holder of 0.03% of company’s stock.